- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2011-02-15 17:39:37
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2011-02-15 17:39:37
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1392380||Gevo Inc.||GEVO||Industrial Organic Chemicals (2860)||870747704|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1083218||Ganesh Kishore||No. 36-01, Level Menara Dion |
27, Jalan Sultan Ismail
50250 Kuala Lumpur N8
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Common Stock||Acquisiton||2011-02-14||1,540,739||$0.00||1,540,739||No||4||C||Indirect||By fund|
|Common Stock||Acquisiton||2011-02-14||130,686||$15.00||1,671,425||No||4||P||Indirect||By fund|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Series C Preferred Stock||Disposition||2011-02-14||802,920||$0.00||802,920||$0.00|
|Common Stock||Series D Preferred Stock||Disposition||2011-02-14||497,160||$0.00||497,160||$0.00|
|Common Stock||Series D-1 Preferred Stock||Disposition||2011-02-14||126,515||$0.00||240,659||$0.00|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- Represents the aggregate number of shares of common stock deemed to be beneficially owned by the reporting person following conversion of the shares of preferred stock previously deemed to be beneficially owned by the reporting person and reflected in Table II of this Form 4.
- Upon completion of the Issuer's initial public offering of common stock, all shares of preferred stock deemed to be beneficially owned by the reporting person, other than shares of Series D-1 Preferred Stock, were automatically converted into shares of the Issuer's common stock on a one-for-one basis and had no expiration date.
- Upon completion of the Issuer's initial public offering and in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on May 4, 2010, a copy of which is attached as Exhibit 3.1 to the Issuer's Registration Statement on Form S-1 (File No. 333-168792), as amended, initially filed with the Securities and Exchange Commission on August 12, 2010, the Series D-1 Preferred Stock was automatically converted into shares of the Issuer's common stock at a ratio of 1:1.90222 and had no expiration date.
- The securities were issued to Malaysian Life Sciences Capital Fund Ltd. ("Malaysian Life Sciences"). Ganesh Kishore, Ph.D. is the Chief Executive Officer of Malaysian Life Sciences and may be held to have voting and dispositive power over shares held by the fund. Dr. Kishore disclaims beneficial ownership of shares held by Malaysian Life Sciences except to the extent of his pecuniary interest therein.